Corrigendum to "Efficient in vitro expansion of JC virus-specific CD8+ T-cell responses by JCV peptide-stimulated dendritic cells from patients with progressive multifocal leukoencephalopathy" [Virology 383 (2009) 173-177] (DOI:10.1016/j.virol.2008.10.046);Efficient in vitro expansion of JC virus-specific CD8+ T-cell responses by JCV peptide-stimulated dendritic cells from patients with progressive multifocal leukoencephalopathy

Virology

Volumn 383, Issue 2, 2009, Pages 173-177

  Marzocchetti, Angela ^a   Lima, Marco ^a,b   Tompkins, Troy ^a   Kavanagh, Daniel G ^c   Gandhi, Rajesh T ^c   O'Neill, David W ^d   Bhardwaj, Nina ^d   Koralnik, Igor J ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b INSTITUTO OSWALDO CRUZ   (Brazil)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Dendritic cells; JC virus; Progressive multifocal leukoencephalopathy

Indexed keywords

HLA A ANTIGEN;

ADULT; AGED; ARTICLE; CD8+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IN VITRO STUDY; JC VIRUS; PRIORITY JOURNAL; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY;

JC POLYOMAVIRUS;

EID: 58149117509     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2009.10.038     Document Type: Erratum

References (24)

1. Adams S., O'Neill D.W., and Bhardwaj N. Recent advances in dendritic cell biology. J. Clin. Immunol. 25 3 (2005) 177-188
2. Antinori A., Cingolani A., Lorenzini P., Giancola M.L., Uccella I., Bossolasco S., Grisetti S., Moretti F., Vigo B., Bongiovanni M., Del Grosso B., Arcidiacono M.I., Fibbia G.C., Mena M., Finazzi M.G., Guaraldi G., Ammassari A., d'Arminio Monforte A., Cinque P., De Luca A., and Italian Registry Investigative Neuro AIDS Study Group. Clinical epidemiology and survival of progressive multifocal leucoencepalophathy in the era of highly active antiretroviral therapy: data from the Italian Registry Investigative Neuro AIDS (IRINA). J. Neurovirol. 9 Suppl. 1 (2003) 47-54
3. Berger J.R., and Koralnik I.J. Progressive multifocal leukoencephalopathy and natalizumab-unforeseen consequences. N. Engl. J. Med. 353 4 (2005) 414-416
4. De Luca A., Ammassari A., Cingolani A., Giancola M.L., and Antinori A. Disease progression and poor survival of AIDS-associated progressive multifocal leukoencepalophathy despite highly active antiretroviral therapy. AIDS 12 (1998) 1937-1938
5. Dhodapkar M.V., and Bhardwaj N. Active immunization of humans with dendritic cells. J. Clin. Immunol. 20 3 (2000) 167-174
6. Du Pasquier R.A., Kuroda M.J., Schmitz J.E., Zheng Y., Martin K., Peyerl F.W., Lifton M., Gorgone D., Autissier P., Letvin N.L., and Koralnik I.J. Low frequency of cytotoxic T lymphocytes against the novel HLA-A*0201-restricted JC virus epitope VP1 (p36) in patients with proven or possible progressive multifocal leukoencephalopathy. J. Virol. 77 22 (2003) 11918-11926
7. Du Pasquier R.A., Kuroda M.J., Zheng Y., Jean-Jacques J., Letvin N.L., and Koralnik I.J. A prospective study demonstrates an association between JC virus-specific cytotoxic T lymphocytes and the early control of progressive multifocal leukoencephalopathy. Brain 127 Pt. 9 (2004) 1970-1978
8. Du Pasquier R.A., Autissier P., Zheng Y., Jean-Jacques J., and Koralnik I.J. Presence of JC virus-specific CTL in the cerebrospinal fluid of PML patients: rationale for immune-based therapeutic strategies. AIDS 19 19 (2005) 2069-2076
9. Du Pasquier R.A., Stein M.C., Lima M.A., Dang X., Jean-Jacques J., Zheng Y., Letvin N.L., and Koralnik I.J. JC virus induces a vigorous CD8+ cytotoxic T cell response in multiple sclerosis patients. J. Neuroimmunol. 176 1-2 (2006) 181-186
10. Hsieh S.M., Pan S.C., Hung C.C., Chen M.Y., and Chang S.C. Differential impact of late-stage HIV-1 infection on in vitro and in vivo maturation of myeloid dendritic cells. J. Acquir. Immune Defic. Syndr. 33 4 (2003) 413-419
11. June C.H. Adoptive T cell therapy for cancer in the clinic. J. Clin. Invest. 117 6 (2007) 1466-1476
12. Koralnik I.J. Progressive multifocal leukoencephalopathy revisited: has the disease outgrown its name?. Ann Neurol. 60 2 (2006) 162-173
13. Koralnik I.J., Boden D., Mai V.X., Lord S.C.I., and Letti N.L. JC virus DNA load in patients with and without progressive multifocal leukoencephalopathy. Neurology 52 2 (1999) 253-260
14. Koralnik I.J., Du Pasquier R.A., Kuroda M., Schmitz J.E., Dang X., Zheng Y., Lifton M., and Letvin N.L. Association of prolonged survival in HLA-A2+ progressive multifocal leukoencephalopathy patients with a cytotoxic T lymphocyte response specific for a dominant JC virus epitope. J. Immunol. 168 (2002) 499-504
15. Lima M.A., Marzocchetti A., Autissier P., Tompkins T., Chen Y., Gordon J., Clifford D.B., Gandhi R.T., Venna N., Berger J.R., and Koralnik I.J. Frequency and phenotype of JC virus-specific CD8+ T lymphocytes in the peripheral blood of patients with progressive multifocal leukoencephalopathy. J. Virol. 81 7 (2007) 3361-3368
16. Lu W., Arraes L.C., Ferreira W.T., and Andrieu J.M. Therapeutic dendritic-cell vaccine for chronic HIV-1 infection. Nat. Med. 10 (2004) 1359-1365
17. Miller N., Major E.O., and Wallen W.C. Transfection of human fetal glial cells with molecularly cloned JCV DNA. Prog. Clin. Biol. Res. 105 (1983) 29-40
18. Monaco M.C., Jensen P.N., Hou J., Durham L.C., and Major E.O. Detection of JC virus DNA in human tonsil tissue: evidence for site of initial viral infection. J. Virol. 72 12 (1998) 9918-9923
19. O'Neill D., and Bhardwaj N. Generation of autologous peptide- and protein-pulsed dendritic cells for patient-specific immunotherapy. Methods Mol. Med. 109 (2005) 97-112
20. Velazquez E.F., Jungbluth A.A., Yancovitz M., Gnjatic S., Adams S., O'Neill D., Zavilevich K., Albukh T., Christos P., Mazumdar M., Pavlick A., Polsky D., Shapiro R., Berman R., Spira J., Busam K., Osman I., and Bhardwaj N. Expression of the cancer/testis antigen NY-ESO-1 in primary and metastatic malignant melanoma (MM)-correlation with prognostic factors. Cancer Immun. 12 (2007) 7-11
21. Viscidi R.P., Rollison D.E., Viscidi E., Clayman B., Rubalcaba E., Daniel R., Major E.O., and Shah K.V. Serological cross-reactivities between antibodies to simian virus 40, BK virus, and JC virus assessed by virus-like-particle-based enzyme immunoassays. Clin. Diagn. Lab. Immunol. 10 2 (2003) 278-285
22. Waeckerle-Men Y., Scandella E., Uetz-Von Allmen E., Ludewig B., Gillessen S., Gillessen S., Merkle H.P., Gander B., and Groettrup M. Phenotype and functional analysis of human monocyte-derived dendritic cells loaded with biodegradable poly(lactide-co-glycolide) microspheres for immunotherapy. J. Immunol. Methods 287 1-2 (2004) 109-124
23. Weber T., Trebst C., Frye S., Cinque P., Vago L., Sindic C.J., Schulz-Schaeffer W.J., Kretzschmar H.A., Enzensberger W., Hunsmann G., and Lüke W. Analysis of the systemic and intrathecal humoral immune response in progressive multifocal leukoencephalopathy. J. Infect. Dis. 176 1 (1997) 250-254
24. +) T cells with JCV-infected glial cells. J. Neurovirol. 12 2 (2006) 116